DR. MARK C SCHOLZ M.D. NPI 1346286093

NPI Details

DR. Mark C Scholz, M.D. is a specialist in Marina Del Rey, CA with 43 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Mark C Scholz, M.D. NPI is 1346286093. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1983

The provider's business location address is:

4560 ADMIRALTY WAY STE 111
MARINA DEL REY, CA
ZIP 90292-424
Phone: (310) 827-7707
Fax: (310) 574-4002

The NPI 1346286093 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, cabazitaxel, 1 mg (HCPCS:J9043)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Phosphatase, prostatic (prostate enzyme) level (HCPCS:84066)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Testosterone (hormone) level, total (HCPCS:84403)
• Sex hormone binding globulin (protein) level (HCPCS:84270)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Gonadotropin, follicle stimulating (reproductive hormone) level (HCPCS:83001)
• Gonadotropin, luteinizing (reproductive hormone) level (HCPCS:83002)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Magnesium level (HCPCS:83735)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Complete ultrasound of abdomen and pelvis artery and vein blood flow (HCPCS:93975)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Injection, amikacin sulfate, 100 mg (HCPCS:J0278)
• Urinalysis, manual test (HCPCS:81002)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Insertion of needle into vein (3 years or older) (HCPCS:36410)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, lidocaine hcl for intravenous infusion, 10 mg (HCPCS:J2001)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Biopsy of prostate gland (HCPCS:55700)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Drawing of blood for a medical problem (HCPCS:99195)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)

The enumeration date for this NPI number is 6/21/2006 and was last updated on 8/29/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: